# OnCo record adebrelimab (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/adebrelimab/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "adebrelimab" ;
  schema:name "Adebrelimab"@en ;
  schema:description "Adebrelimab is Hengrui's PD-L1 antibody, approved in China for first-line extensive-stage small cell lung cancer on the CAPSTONE-1 trial."@en ;
  schema:url <https://onco.cc/drugs/adebrelimab/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.hengrui.com/en/>, <https://doi.org/10.1016/S1470-2045(22)00224-8>, <https://www.nmpa.gov.cn> ;
  onco:status "approved" ;
  onco:tag "china" ;
  onco:modality "Monoclonal antibody (anti-PD-L1, humanised IgG4)" ;
  schema:alternateName "Arelili" ;
  onco:approval "China 2023: First-line extensive-stage small cell lung cancer with carboplatin and etoposide (CAPSTONE-1)" ;
  onco:cancers <https://onco.cc/cancers/sclc/>, <https://onco.cc/cancers/extensive-stage-sclc/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/technologies/monoclonal-antibody/> ;
  onco:targets <https://onco.cc/targets/pdl1/> ;
  onco:companies <https://onco.cc/companies/hengrui/> ;
  onco:pathways <https://onco.cc/pathways/pd1-checkpoint/> ;
  onco:terms <https://onco.cc/terms/limited-extensive-stage/> ;
  onco:trials <https://onco.cc/trials/capstone-1/>, <https://onco.cc/trials/nct07168200/>, <https://onco.cc/trials/nct06589778/>, <https://onco.cc/trials/nct07059221/>, <https://onco.cc/trials/nct06512051/>, <https://onco.cc/trials/nct07071714/>, <https://onco.cc/trials/nct07229729/>, <https://onco.cc/trials/nct06754930/>, <https://onco.cc/trials/nct06840002/>, <https://onco.cc/trials/nct06222879/>, <https://onco.cc/trials/nct06465563/>, <https://onco.cc/trials/nct06474455/>, <https://onco.cc/trials/nct07229586/>, <https://onco.cc/trials/nct06247956/>, <https://onco.cc/trials/nct07111832/>, <https://onco.cc/trials/nct06778031/>, <https://onco.cc/trials/nct05482568/>, <https://onco.cc/trials/nct07268040/>, <https://onco.cc/trials/nct06639347/>, <https://onco.cc/trials/nct07110571/>, <https://onco.cc/trials/nct06385678/>, <https://onco.cc/trials/nct07679360/>, <https://onco.cc/trials/nct06915142/>, <https://onco.cc/trials/nct07028281/>, <https://onco.cc/trials/nct07393542/>, <https://onco.cc/trials/nct06417554/>, <https://onco.cc/trials/nct07522151/>, <https://onco.cc/trials/nct07241767/>, <https://onco.cc/trials/nct06879145/>, <https://onco.cc/trials/nct06474468/>, <https://onco.cc/trials/nct06703177/>, <https://onco.cc/trials/nct05671822/>, <https://onco.cc/trials/nct07296341/>, <https://onco.cc/trials/nct07073534/> .